Five days af­ter re­gain­ing the helm at Cure­Vac — and 1 day af­ter con­tro­ver­sy erupt­ed — In­g­mar Ho­err makes sur­prise ex­it

Five days ago, Cure­Vac founder and orig­i­nal CEO In­g­mar Ho­err grabbed back the reins at the Ger­man biotech, lat­er ex­plain­ing to us that at that point, with a glob­al coro­n­avirus cri­sis un­der­way, the com­pa­ny need­ed a sci­en­tist at the helm.

Yes­ter­day, word got out that the Trump ad­min­is­tra­tion was try­ing to co-opt the mR­NA tech that Cure­Vac had pi­o­neered, promis­ing it could de­vel­op a new vac­cine that could be quick­ly man­u­fac­tured for mil­lions of peo­ple. Eu­ro­pean au­thor­i­ties were livid at the idea of be­ing squeezed out by the US gov­ern­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER